Literature DB >> 2459197

Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes.

P Langlade-Demoyen1, F Michel, A Hoffenbach, E Vilmer, G Dadaglio, F Garicia-Pons, C Mayaud, B Autran, S Wain-Hobson, F Plata.   

Abstract

The CTL response to HIV was analyzed in humans and in mice. By using a novel and strictly autologous lymphocyte culture system, human CTL lines were established with PBL from seropositive asymptomatic donors and from patients suffering from AIDS or presenting AIDS-related complex. CTL from HLA-A2 donors recognize and kill murine P815 mastocytoma cells doubly transfected with the human HLA-A2 gene and the HIV env gene; they also kill HLA-compatible human macrophages infected with HIV. CTL specific for the HIV env Ag were also generated in BALB/c mice by immunization with syngeneic murine cells transfected with the HIV env gene. Human and murine HIV-immune CTL populations belong to the CD8 subset of T lymphocytes and are restricted by class I HLA or H-2 transplantation Ag, respectively, in the recognition of HIV env Ag. The two different experimental systems presented here can be used to study CD8 lymphocyte immunity against HIV. The murine model of CTL immunity offers the additional advantage of avoiding the manipulation of infectious virus isolates.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459197

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection.

Authors:  P Klenerman; R E Phillips; C R Rinaldo; L M Wahl; G Ogg; R M May; A J McMichael; M A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

2.  Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.

Authors:  D Emilie; M Peuchmaur; M C Maillot; M C Crevon; N Brousse; J F Delfraissy; J Dormont; P Galanaud
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

3.  Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections.

Authors:  G Vanham; L Kestens; P Gigase; R Colebunders; M Vandenbruaene; L Brijs; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

4.  An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.

Authors:  A Hosmalin; M Clerici; R Houghten; C D Pendleton; C Flexner; D R Lucey; B Moss; R N Germain; G M Shearer; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  Cytotoxic activity against maedi-visna virus-infected macrophages.

Authors:  W C Lee; I McConnell; B A Blacklaws
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Processing of the glycoprotein of feline immunodeficiency virus: effect of inhibitors of glycosylation.

Authors:  E B Stephens; E Monck; K Reppas; E J Butfiloski
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats.

Authors:  W Song; E W Collisson; P M Billingsley; W C Brown
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Ovine lentivirus is macrophagetropic and does not replicate productively in T lymphocytes.

Authors:  M D Gorrell; M R Brandon; D Sheffer; R J Adams; O Narayan
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment.

Authors:  G Dadaglio; F Michel; P Langlade-Demoyen; P Sansonetti; D Chevrier; F Vuillier; F Plata; A Hoffenbach
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.